CPLM 1.0 - Compendium of Protein Lysine Modification
TagContent
CPLM ID CPLM-023923
UniProt Accession
Genbank Protein ID
Genbank Nucleotide ID
Protein Name
 Transcription factor MafB 
Protein Synonyms/Alias
 Maf-B; V-maf musculoaponeurotic fibrosarcoma oncogene homolog B 
Gene Name
 MAFB 
Gene Synonyms/Alias
 KRML 
Created Date
 July 27, 2013 
Organism
 Homo sapiens (Human) 
NCBI Taxa ID
 9606 
Lysine Modification
Position
Peptide
Type
References
32DLLKFDVKKEPLGRAsumoylation[1, 2]
297ERDAYKVKCEKLANSsumoylation[1]
Reference
 [1] SUMO modification regulates MafB-driven macrophage differentiation by enabling Myb-dependent transcriptional repression.
 Tillmanns S, Otto C, Jaffray E, Du Roure C, Bakri Y, Vanhille L, Sarrazin S, Hay RT, Sieweke MH.
 Mol Cell Biol. 2007 Aug;27(15):5554-64. [PMID: 17548468]
 [2] SUMOylation negatively regulates transcriptional and oncogenic activities of MafA.
 Kanai K, Reza HM, Kamitani A, Hamazaki Y, Han SI, Yasuda K, Kataoka K.
 Genes Cells. 2010 Sep 1;15(9):971-82. [PMID: 20718938
Functional Description
 Acts as a transcriptional activator or repressor. Plays a pivotal role in regulating lineage-specific hematopoiesis by repressing ETS1-mediated transcription of erythroid-specific genes in myeloid cells. Required for monocytic, macrophage, podocyte and islet beta cell differentiation. Involved in renal tubule survival and F4/80 maturation. Activates the insulin and glucagon promoters. Together with PAX6, transactivates weakly the glucagon gene promoter through the G1 element. SUMO modification controls its transcriptional activity and ability to specify macrophage fate. Binds element G1 on the glucagon promoter (By similarity). Involved either as an oncogene or as a tumor suppressor, depending on the cell context. 
Sequence Annotation
 DOMAIN 238 301 bZIP.
 REGION 238 263 Basic motif (By similarity).
 REGION 266 287 Leucine-zipper (By similarity).
 CROSSLNK 32 32 Glycyl lysine isopeptide (Lys-Gly)
 CROSSLNK 297 297 Glycyl lysine isopeptide (Lys-Gly)  
Keyword
 Activator; Complete proteome; Disease mutation; DNA-binding; Isopeptide bond; Nucleus; Proto-oncogene; Reference proteome; Repressor; Transcription; Transcription regulation; Tumor suppressor; Ubl conjugation. 
Sequence Source
 UniProt (SWISSPROT/TrEMBL); GenBank; EMBL 
Protein Length
 323 AA 
Protein Sequence
MAAELSMGPE LPTSPLAMEY VNDFDLLKFD VKKEPLGRAE RPGRPCTRLQ PAGSVSSTPL 60
STPCSSVPSS PSFSPTEQKT HLEDLYWMAS NYQQMNPEAL NLTPEDAVEA LIGSHPVPQP 120
LQSFDSFRGA HHHHHHHHPH PHHAYPGAGV AHDELGPHAH PHHHHHHQAS PPPSSAASPA 180
QQLPTSHPGP GPHATASATA AGGNGSVEDR FSDDQLVSMS VRELNRHLRG FTKDEVIRLK 240
QKRRTLKNRG YAQSCRYKRV QQKHHLENEK TQLIQQVEQL KQEVSRLARE RDAYKVKCEK 300
LANSGFREAG STSDSPSSPE FFL 323 
Gene Ontology
 GO:0005634; C:nucleus; TAS:ProtInc.
 GO:0005667; C:transcription factor complex; IEA:Compara.
 GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
 GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro.
 GO:0008134; F:transcription factor binding; IDA:UniProtKB.
 GO:0035284; P:brain segmentation; IEA:Compara.
 GO:0042472; P:inner ear morphogenesis; IEA:Compara.
 GO:0045647; P:negative regulation of erythrocyte differentiation; IDA:UniProtKB.
 GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Compara.
 GO:0007585; P:respiratory gaseous exchange; IEA:Compara.
 GO:0021571; P:rhombomere 5 development; IEA:Compara.
 GO:0021572; P:rhombomere 6 development; IEA:Compara.
 GO:0007379; P:segment specification; IEA:Compara.
 GO:0007423; P:sensory organ development; TAS:ProtInc.
 GO:0006351; P:transcription, DNA-dependent; IEA:UniProtKB-KW. 
Interpro
 IPR004827; bZIP.
 IPR004826; bZIP_Maf.
 IPR008917; Euk_TF_DNA-bd.
 IPR013592; Maf_TF_N.
 IPR024874; Transciption_factor_Maf. 
Pfam
 PF03131; bZIP_Maf
 PF08383; Maf_N 
SMART
 SM00338; BRLZ 
PROSITE
 PS50217; BZIP
 PS00036; BZIP_BASIC 
PRINTS